MAPK3 and neoplasm: Consistent with in vitro data, protein analyses of tumor tissues revealed that vemurafenib treatment significantly increased ERK1/2 phosphorylation, as well as γH2AX levels, in tumors from Mel 272 Spry1KO clone 4 cells (Fig. 7i).